THE EFFICACY OF DEEP REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION OVER THE MEDIAL PREFRONTAL CORTEX IN OBSESSIVE COMPULSIVE DISORDER: RESULTS FROM AN OPEN-LABEL STUDY
Background Significant numbers of patients with obsessive compulsive disorder (OCD) respond minimally to currently available treatments. Furthermore, the application of both high‐ and low‐frequency repetitive transcranial magnetic stimulation (rTMS) to dorsolateral prefrontal cortex has shown to be...
Saved in:
Published in | Depression and anxiety Vol. 32; no. 6; pp. 445 - 450 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.06.2015
John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1091-4269 1520-6394 |
DOI | 10.1002/da.22363 |
Cover
Summary: | Background
Significant numbers of patients with obsessive compulsive disorder (OCD) respond minimally to currently available treatments. Furthermore, the application of both high‐ and low‐frequency repetitive transcranial magnetic stimulation (rTMS) to dorsolateral prefrontal cortex has shown to be ineffective in the reduction of OCD symptoms. In this study, we instead targeted the medial prefrontal cortex (mPFC) and applied low‐frequency rTMS to patients with OCD and assessed their clinical response.
Methods
In an open‐label design, 10 OCD patients with no other current axis I psychiatric disorders were recruited. Twelve hundred pulses of 1‐Hz frequency were applied over the mPFC (Brodmann areas 24 and 32) using a double‐cone coil for 10 days. Regions of interest were located on participants’ MRIs using neuronavigation software. Patients’ symptoms were rated using the Yale‐Brown Obsessive Compulsive Scale (Y‐BOCS).
Results
All patients demonstrated improvement in their OCD symptoms after 10 sessions of rTMS as shown by a mean improvement in Y‐BOCS score of 39% (SD = 15%; P < .001, F = 62.95). This improvement persisted 1 month following the last session of rTMS.
Conclusions
Our results suggest the use of low frequency deep rTMS as a promising and robust intervention in OCD symptom reduction. However, this study is limited by its open‐label nature and its lack of a control group, so further randomized clinical trials are needed to confirm these results. |
---|---|
Bibliography: | istex:4F4A339E7E6BF39020A724DF3FC619F07ABB35FE ark:/67375/WNG-1B22QHFB-2 Manitoba Medical Service Foundation; - No. 810-10; No. . ArticleID:DA22363 Contract grant sponsor: Manitoba Medical Service Foundation; Contract grant number: 810‐10. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1091-4269 1520-6394 |
DOI: | 10.1002/da.22363 |